Cargando…

Impact of Fc receptors and host characteristics on myeloid phagocytic response to rituximab-treated 3D-cultured B-cell lymphoma

Antibody-based immunotherapy is successful in treating cancer, but its effectiveness varies among patients. Therefore, understanding myeloid phagocytic responses to therapeutic antibodies is critical. Immunoglobulin Fc receptors and host characteristics were evaluated in phagocytosis of 3D-cultured...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kleinau, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640869/ https://www.ncbi.nlm.nih.gov/pubmed/38020313 http://dx.doi.org/10.1093/immadv/ltad025

Ejemplares similares

Exploring complement-dependent cytotoxicity by rituximab isotypes in 2D and 3D-cultured B-cell lymphoma
por: Lara, Sandra, et al.
Publicado: (2022)

Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
por: Thomson, A. W., et al.
Publicado: (1979)

Induction and Suppression of Collagen-Induced Arthritis Is Dependent on Distinct Fcγ Receptors
por: Kleinau, Sandra, et al.
Publicado: (2000)

Modulation of Fc receptors of mononuclear phagocytes by immobilized antigen-antibody complexes. Quantitative analysis of the relationship between ligand number and Fc receptor response
Publicado: (1983)

Fc receptor modulation in mononuclear phagocytes maintained on immobilized immune complexes occurs by diffusion of the receptor molecule
Publicado: (1983)

Neutrophil-Mediated Phagocytic Host Defense Defect in Myeloid Cftr-Inactivated Mice
por: Ng, Hang Pong, et al.
Publicado: (2014)

Connective tissue proteins and phagocytic cell function. Laminin enhances complement and Fc-mediated phagocytosis by cultured human macrophages
Publicado: (1985)

CR3 ruffles FcγR’s claim over phagocytic cups
por: Frautschy, S.A.
Publicado: (2021)

High synovial expression of the inhibitory FcγRIIb in rheumatoid arthritis
por: Magnusson, Sofia E, et al.
Publicado: (2007)

Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance
por: Kim, Hee Kyung, et al.
Publicado: (2020)

Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity
por: Robinson, James I., et al.
Publicado: (2022)

TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria
por: N'Diaye, Elsa-Noah, et al.
Publicado: (2009)

Characteristics of pulmonary complications in non-Hodgkin’s lymphoma patients treated with rituximab-containing chemotherapy and impact on survival
por: Keefer, Kimberly, et al.
Publicado: (2018)

Bromodomain Inhibitors Modulate FcγR-Mediated Mononuclear Phagocyte Activation and Chemotaxis
por: Banham, Gemma D., et al.
Publicado: (2022)

The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy
por: Uchida, Junji, et al.
Publicado: (2004)

Fc receptor-mediated binding and endocytosis by human mononuclear phagocytes: monomeric IgG is not endocytosed by U937 cells and monocytes
Publicado: (1985)

Immune Complex-Induced, Nitric Oxide-Mediated Vascular Endothelial Cell Death by Phagocytes Is Prevented with Decoy FcγReceptors
por: Mula, Ramanjaneya V. R., et al.
Publicado: (2016)

Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma
por: Hu, Xin, et al.
Publicado: (2017)

Elevated Membrane and Soluble CD64: A Novel Marker Reflecting Altered FcγR Function and Disease in Early Rheumatoid Arthritis That Can Be Regulated by Anti-Rheumatic Treatment
por: Matt, Peter, et al.
Publicado: (2015)

Targeting FcγRIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma
por: Jiang, Vivian Changying, et al.
Publicado: (2022)

IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia
por: Schmidt, David E., et al.
Publicado: (2020)

Centrality of Myeloid-Lineage Phagocytes in Particle-Triggered Inflammation and Autoimmunity
por: Favor, Olivia K., et al.
Publicado: (2021)

Effect of Fc-γ Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation
por: Sakai, Hiroshi, et al.
Publicado: (2017)

Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy
por: Junlén, Henna-Riikka, et al.
Publicado: (2020)

Leuconostoc sp. Meningitis in a Patient Treated with Rituximab for Mantle Cell Lymphoma
por: Holik, Hrvoje, et al.
Publicado: (2015)

Follicular Lymphomas of Oral Region Treated by Rituximab Monotherapy: About Two Cases
por: Montaner, Sylvain, et al.
Publicado: (2018)

Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1)
por: Raggi, Federica, et al.
Publicado: (2020)

Fungal Invasion of Normally Non-Phagocytic Host Cells
por: Filler, Scott G, et al.
Publicado: (2006)

Dangerous Liaisons: Interactions of Cryptococcus neoformans with Host Phagocytes
por: Gaylord, Elizabeth A., et al.
Publicado: (2020)

Treating refractory post-herpetic anti-N-methyl-d-aspartate receptor encephalitis with rituximab
por: Strippel, Christine, et al.
Publicado: (2017)

Rituximab maintenance therapy of follicular lymphoma in clinical practice
por: Dührsen, Ulrich, et al.
Publicado: (2018)

Rituximab in the treatment of non-Hodgkin’s lymphoma
por: Hauptrock, Beate, et al.
Publicado: (2008)

Maintenance rituximab in Veterans with follicular lymphoma
por: Halwani, Ahmad S., et al.
Publicado: (2020)

Rheumatoid peripheral blood phagocytes are primed for activation but have impaired Fc-mediated generation of reactive oxygen species
por: Fairhurst, Anna-Marie, et al.
Publicado: (2007)

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy
por: Hussain, Khiyam, et al.
Publicado: (2022)

Chemokine Receptors and Phagocyte Biology in Zebrafish
por: Sommer, Frida, et al.
Publicado: (2020)

Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients
por: Wei, Kai-Che, et al.
Publicado: (2018)

Cryoglobulinemic membranoproliferative glomerulonephritis associated with mucosa-associated lymphoid tissue lymphoma treated with rituximab
por: Ha, Austin Y., et al.
Publicado: (2016)

B cell non-Hodgkin's lymphoma: rituximab safety experience
por: Mohrbacher, Ann
Publicado: (2005)

Intralesional rituximab for cutaneous manifestations of systemic B-cell lymphoma
por: Maillet-Lebel, Nicole, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rt3kr7senvfumu2kakk5gak2cg